{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-009009","form_type":"8-K","ticker":"ACRS","cik":"0001557746","company_name":"Aclaris Therapeutics, Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.945512+00:00","generated_at":"2026-06-01T05:33:54.446485+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Aclaris shareholders elect two directors, approve say-on-pay, ratify auditor at 2024 annual meeting","bullets":["Elected Christopher Molineaux (29.2M for, 16.2M withheld) and Vincent Milano (42.3M for, 3.1M withheld) as directors.","Advisory vote on executive compensation approved: 29.0M for, 16.3M against, 21k abstain, with 12.5M broker non-votes.","Ratified PricewaterhouseCoopers as auditor for FY2024: 56.6M for, 1.2M against, 23k abstain.","Turnout of 81.09% (57.8M of 71.3M shares outstanding) present or represented at meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-009009","json":"https://secwatch.observer/filing/0001558370-24-009009.json","markdown":"https://secwatch.observer/filing/0001558370-24-009009.md","text":"https://secwatch.observer/filing/0001558370-24-009009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024009009/0001558370-24-009009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024009009/acrs-20240606x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:33:54.446485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}